Bayesian Capital Management’s Diebold Nixdorf Incorporated DBD Stock Holding History
Bought
Maintained
Sold
Other funds holding DBD
GI
SI
AA
Bayesian Capital Management's DBD Position: Q3 2019 in Review
Bayesian Capital Management sold out of Diebold Nixdorf Incorporated (DBD) in Q3 2019, closing a stake of 11,900 shares — an estimated $109K sold.
Bayesian Capital Management first reported a position in DBD in Q1 2017 and held it in 3 quarters. The position peaked at $278K in Q1 2019. 206 funds tracked by Wall St. Rank hold DBD as of Q3 2019.
- Bayesian Capital Management reported no remaining Diebold Nixdorf Incorporated position as of Q3 2019 after selling out during the quarter.
- Bayesian Capital Management sold 11,900 Diebold Nixdorf Incorporated shares in Q3 2019, an estimated $109K.
- Bayesian Capital Management first reported a position in Diebold Nixdorf Incorporated in Q1 2017 and held it in 3 quarters.
- Bayesian Capital Management's Diebold Nixdorf Incorporated position peaked at $278K in Q1 2019.
- 206 funds tracked by Wall St. Rank held Diebold Nixdorf Incorporated as of Q3 2019.
Based on Bayesian Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.